Global Health Technologies Coalition Global Health Technologies Coalition
  • Why R&D
  • R&D Facts
  • In Your State
  • Solutions
  • Breakthroughs Blog
  • News & Events
  • Resources
  • About Us
Stay Informed

Global health R&D delivers forArkansas

Map
Arkansas
Select a new state
Select a State
Alabama Alaska Arizona Arkansas California Colorado Connecticut Delaware Florida Georgia Hawaii Idaho Illinois
Indiana Iowa Kansas Kentucky Louisiana Maine Maryland Massachusetts Michigan Minnesota Mississippi Missouri Montana
Nebraska Nevada New Hampshire New Jersey New Mexico New York North Carolina North Dakota Ohio Oklahoma Oregon Pennsylvania Rhode Island
South Carolina South Dakota Tennessee Texas Utah Vermont Virginia Washington West Virginia Wisconsin Wyoming

US government investment in global health R&D has delivered

$2.4 million
to Arkansas research institutions
Arkansas

Neglected diseases in Arkansas

Chikungunya cases
Chikungunya cases
12
Dengue cases
Dengue cases
11
HIV diagnoses
HIV diagnoses
2412
Malaria cases
Malaria cases
29
Tuberculosis cases
Tuberculosis cases
744
West Nile cases
West Nile cases
143
Zika cases
Zika cases
15
Arkansas's top USG-funded global health R&D institutions

Arkansas's top USG-funded global health R&D institutions

University of Arkansas
$2.4 million
Arkansas industry in global health R&D

Arkansas industry in global health R&D

AC Diagnostics
Location(s): Fayetteville

Arkansas's top areas of global health R&D by USG funding

76.7%
Malaria
15.4%
Tuberculosis
7.9%
Neglected tropical diseases
Dengue
Global health R&D at work in Arkansas
Global health R&D at work in Arkansas

Scientists at University of Arkansas for Medical Sciences (UAMS) have been awarded federal funding from the National Institutes of Health to supports research on infectious diseases. This funding has enabled UAMS to establish the Center for Microbial Pathogenesis and Host Inflammatory Responses, which focuses on pathogens—bacteria, viruses, and microorganisms—and the disease responses they cause in humans. The center has advanced research on malaria, pneumonic plague, leishmaniasis—a parasitic disease that causes disfiguring skin lesions—and other deadly diseases. By trying to understand how pathogens cause disease in humans, the scientists hope to develop new treatments and technologies. One other new idea being developed at UAMS is a non-invasive malaria detection laser for spotting parasite-infected cells traveling through blood vessels.

Download PDF
Map
Select a new state
Footnotes
  • Methodology
  • USG global health R&D investment to state research institutions/Top USG-funded global health R&D institutions: Authors' analysis of USG investment data from the G-FINDER survey, including funding for R&D for neglected diseases from 2007–2015 and for Ebola and select viral hemorrhagic fevers from 2014–2015. Reflects USG funding received by entities in state including academic and research institutions, product development partnerships, other nonprofits, select corporations, and government research institutions, as well as self-funding or other federal agency transfers received by federal agencies located in state; but excludes pharmaceutical industry data which is aggregated and anonymized in the survey for confidentiality purposes. See methodology for additional details.
  • Case study photo: CDC/ Melissa Dankel
Close
advancing innovation to save lives

© 2009–2021, PATH, as secretariat of the Global Health Technologies Coalition.

  • Stay Informed
  • Join Us
  • Contact Us
  • GHTC Member Log In